Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-000888
Filing Date
2023-01-05
Accepted
2023-01-05 15:07:09
Documents
1
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3348
  Complete submission text file 0000899243-23-000888.txt   4691
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3516 WEST 33RD AVE VANCOUVER A1 V6N 2H4
Business Address
Wood David S. (Reporting) CIK: 0001826902 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 23510936